STACY MCBRIDE: Open Payments
NPI 1588023675 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,166 in 164 payments from 25 companies in 2025. Trend: 2023 $3,605 · 2024 $3,591 · 2025 $3,166
Food & beverage: $3,166
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $564 |
| AstraZeneca Pharmaceuticals LP | 13 | $460 |
| Axsome Therapeutics, Inc. | 6 | $218 |
| Novo Nordisk Inc | 10 | $217 |
| Otsuka America Pharmaceutical, Inc. | 18 | $197 |
| Viatris Specialty LLC | 8 | $190 |
| GlaxoSmithKline, LLC. | 11 | $172 |
| Bayer Healthcare Pharmaceuticals Inc. | 14 | $170 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $165 |
| Alkermes, Inc. | 14 | $149 |
Products named: VRAYLAR, AIRSUPRA, REXULTI, Auvelity, YUPELRI, TRELEGY ELLIPTA, Kerendia, CAPLYTA.
Industry payments across KY — which companies pay providers there.
